|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.93/--
|
企业价值
352.36M
|
资产负债 |
每股账面净值
-7.87
|
现金流量 |
现金流量率
--
|
损益表 |
收益
33.49M
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/11/10 15:07 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program ofthe company includes Artiva-Funded Trials and Collaborator-Funded Trials. |